Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour.
Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H, Jebsen NL, van de Sande M, Jones RL, Haglund F, Timmermans I, Safwat A, Bjerkehagen B, Boye K.
Georgiesh T, et al. Among authors: haglund f.
Br J Cancer. 2022 Nov;127(10):1793-1798. doi: 10.1038/s41416-022-01959-4. Epub 2022 Aug 27.
Br J Cancer. 2022.
PMID: 36030294
Free PMC article.